Cheng-ting Hsu

100 Tzyou Road, 807
Kaohsiung, KHQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 17 publications

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.

Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.

Journal: Cancer medicine

Published: September 14, 2021

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.

Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication.

Journal: World journal of gastroenterology

Published: September 08, 2021

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.

Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison.

Journal: World journal of gastroenterology

Published: August 05, 2021

Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort study.

Seroreversion of hepatitis B surface antigen among subjects with resolved hepatitis B virus infection: A community-based cohort study.

Journal: Journal of gastroenterology and hepatology

Published: May 24, 2021

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.

Genotype distribution, clinical characteristics, and racial differences observed in chronic hepatitis C patients in Pingtung, Taiwan.

Journal: Journal of the Chinese Medical Association : JCMA

Published: January 12, 2021

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.

Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like Group.

Journal: Journal of viral hepatitis

Published: December 11, 2020

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.

Comorbidities in patients with chronic hepatitis C and hepatitis B on hemodialysis.

Journal: Journal of gastroenterology and hepatology

Published: December 08, 2020

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.

Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in Taiwan.

Journal: Scientific reports

Published: October 12, 2020

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).

Establishment of an outreach, grouping healthcare system to achieve microelimination of HCV for uremic patients in haemodialysis centres (ERASE-C).

Journal: Gut

Published: October 04, 2020

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.

Role of hepatitis D virus infection in development of hepatocellular carcinoma among chronic hepatitis B patients treated with nucleotide/nucleoside analogues.

Journal: Scientific reports

Published: August 03, 2020

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Concordance of SVR12, SVR24 and SVR durability in Taiwanese chronic hepatitis C patients with direct-acting antivirals.

Journal: PloS one

Published: July 28, 2020

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.

Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis.

Journal: Clinical and molecular hepatology

Published: July 19, 2020

Showing 1-12 of 17

Last Updated: 09/26/2026